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Varicella zoster virus (VZV) encodes five genes that do not have homologs in herpes simplex virus. One of these genes, VZV
ORF57, is predicted to encode a protein containing 71 amino acids. Antibody to ORF57 protein immunoprecipitated a 6-kDa protein
in the cytosol of VZV-infected cells. Although the homolog of VZV ORF57 in pseudorabies virus, UL3.5, is critical for viral egress
and growth in cell culture, VZV unable to express ORF57 replicated to titers similar to those seen with parental virus. Thus VZV
ORF57 has a different role in viral replication than its pseudorabies virus homolog.
INTRODUCTION
Varicella-zoster virus (VZV) is a member of the alpha-
herpesvirus subfamily. This subfamily is further divided
into the genus Simplexvirus, which includes herpes sim-
plex virus (HSV) and herpesvirus simiae, and Varicello-
virus, which includes VZV, equine herpesvirus type 1
(EHV-1), EHV-4, bovine herpesvirus type 1 (BHV-1), and
pseudorabies virus (PRV).
VZV encodes at least 69 unique genes, and all except
five of these genes have homologs in HSV (Cohen and
Straus, 1996). Three of the five genes, ORFs 1, 13, and 32,
have been shown to be dispensable for replication of
VZV in vitro. ORF1 encodes a membrane protein (Cohen
and Seidel, 1995), whereas ORF32 encodes a phospho-
protein that is posttranslationally modified by the VZV
ORF47 kinase (Reddy et al., 1998). ORF13 encodes the
viral thymidylate synthetase (Cohen and Seidel, 1993).
The other two VZV proteins that do not have HSV ho-
mologs have not been studied.
VZV ORF57 is predicted to encode a 71-amino-acid
protein containing hydrophilic and basic residues (Davi-
son and Scott, 1986). Although VZV ORF57 does not have
a homolog with HSV, it does share positional and limited
sequence homology with other Varicellovirus proteins.
These include EHV-1 gene 59 (Telford et al., 1992), EHV-4
gene 59 (Telford et al., 1998), PRV UL3.5 (Dean et al.,
1993), BHV-1 UL3.5 (Khattar et al., 1995), and infectious
laryngotracheitis virus UL3.5 proteins (Fuchs and Met-
tenleiter, 1996). Although VZV ORF57 protein is predicted
to be 71 amino acids in length, the other proteins range
in size from 72 amino acids for infectious laryngotrache-
itis virus UL3.5 to 220 amino acids for PRV UL3.5. These
proteins have sequence homology in their first 50 amino
acids (Khattar et al., 1995) and contain a large number of
basic amino acids with isoelectric points ranging from 10
to 13. BHV-1 UL3.5 is a virion protein associated with the
tegument or envelope whose role in virus replication is
unknown (Schikora et al., 1998). In contrast, PRV UL3.5
encodes a nonstructural protein that is critical for viral
egress (Fuchs et al., 1996).
Here we show that VZV ORF57 encodes a 6-kDa pro-
tein present in the cytosol of virus-infected cells. Unlike
its PRV counterpart, deletion of VZV ORF57 does not
impair growth of the virus in cell culture.
RESULTS AND DISCUSSION
To verify that ORF57 is expressed in VZV-infected cells,
rabbit antibodies were made to a fusion protein derived
from VZV ORF57. Immunoprecipitation of [35S]methi-
onine-labeled cells showed a 6-kDa protein from VZV-
infected cells using antisera to VZV ORF57 (Fig. 1A). A
similar-sized protein was not present in uninfected cells.
Immunoprecipitations of [32P]orthophosphoric acid-ra-
diolabeled VZV-infected cells were performed to deter-
mine whether the ORF57 protein is phosphorylated. An-
tibody to ORF57 protein did not immunoprecipitate a
phosphoprotein from VZV-infected cells, whereas anti-
body to gE detected the phosphorylated glycoprotein
(data not shown).
Cytosolic and membrane fractions were prepared from
radiolabeled VZV-infected cells to determine where
ORF57 protein is located in infected cells. Immunopre-
cipitation with antibody to ORF57 protein showed that the
protein was located in the cytosolic fraction of infected
cells but not in the membrane fraction (Fig. 2). As a
control for separation of the cellular fractions, VZV gE
localized to the membrane but not the cytosolic fraction.
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Unlike VZV ORF57, PRV UL3.5 is located in the mem-
brane-plus-microsome fraction of virus-infected cells
(Fuchs et al., 1996).
To determine whether ORF57 is essential for growth of
VZV in vitro, cells were transfected with cosmids NotI A,
MstII B, MstII A-57DA, or MstII A-57DB and plasmids
pNotI B and pCMV62. Cytopathic effects, indistinguish-
able from those seen with parental VZV, were present in
cells transfected with the ORF57 deletion mutant cos-
mids. Virion DNA was prepared from cells infected with
VZV ROka and ROka57D, and Southern blots were per-
formed to verify that the genomes had the expected
configurations. Digestion of DNA from VZV ROka57D
with EcoRI showed restriction fragments that were iden-
tical to those seen with the parental virus (Fig. 3A).
Digestion of DNA from ROka with SphI showed a 1.8-kb
band, whereas DNA from ROka57D had a 1.6-kb band
due to the deletion in ORF57 (Fig. 3B).
To verify that cells infected with ROka57D were unable
to express ORF57 protein, infected cells were radiola-
beled and lysates were immunoprecipitated with anti-
body to the proteins. Although cells infected with ROka
expressed a 6-kDa protein that reacted with antibody to
ORF57 protein, ROka57DA- and ROka57DB-infected cells
did not produce a similar-size protein (Fig. 1A). To ensure
that the absence of expression of ORF57 protein was not
due to the lack of VZV gene expression, immunoprecipi-
tations were performed from cells infected with the
ORF57 deletion mutants with antibody to gE. Cells in-
fected with the mutants expressed VZV gE (Fig. 1B).
Melanoma cells were infected with cells containing
the ORF57 mutant virus, and the plaque sizes were
measured to determine whether the absence of ORF57
affects the growth of VZV in vitro. The mean size of
plaques (6 the standard deviation) produced by the
ROka57DA (0.87 6 0.21 mm) was not statistically differ-
ent from the size of plaques produced by ROka (0.80 6
0.16 mm) in melanoma cells (P 5 .21, Tukey’s multiple
comparison test). The size of plaques from the ORF57
mutant and ROka were similar in U2OS osteosarcoma
cells (0.44 6 0.09 and 0.38 6 0.04 mm, respectively) and
in schwannoma cells (0.60 6 0.07 and 0.72 6 0.08,
respectively).
To further verify that the ORF57 deletion mutants were
not impaired for growth in vitro, melanoma cells were
infected with the ORF57 mutants and the titer of virus
was determined at different time points. VZV ROka57D
grew to titers similar to those seen in cells infected with
the parental (ROka) virus (Fig. 4).
Although the VZV ORF57 mutant was not impaired for
growth in cell culture, a PRV UL3.5 mutant that truncates
the protein after the first 10 amino acids was severely
impaired for growth in vitro (Fuchs et al., 1996). The PRV
UL3.5 deletion mutant was blocked for the development
and release of virions from infected cells and required a
complementing cell line to produce plaques.
Although BHV-1 UL3.5 and PRV UL3.5 proteins show
limited sequence identity (26%) and difference in size,
the BHV-1 protein can complement the PRV protein
(Fuchs et al., 1997). These findings, along with the
observation that other alphaherpesviruses have UL3.5
homologs led Fuchs et al. (1997) to postulate that
“members of this gene family might contribute to the
same general step of alphaherpesvirus maturation
and egress.” Our observation that VZV ORF57, the
homolog of PRV UL3.5, is fully dispensable for repli-
FIG. 2. VZV ORF57 is a cytosolic protein. Cells infected with VZV
ROka were radiolabeled with [35S]methionine, and membrane (A) and
cytosolic (B) fractions were prepared. An aliquot of each fraction was
immunoprecipitated using antibody to ORF57 (lanes 1 and 2) or VZV gE
(lanes 3 and 4) proteins. VZV ORF57 protein is detected only in the
cytosolic fraction of cells infected with VZV (arrow), whereas gE is
present in the membrane fraction (arrow). Numbers refer to molecular
weight of proteins in kilodaltons.
FIG. 1. Characterization of ORF57 protein from VZV-infected cells. (A)
Antibody to ORF57 protein immunoprecipitates a 6-kDa protein in VZV
ROka-infected cells (arrow) but not in ROka57DA- or ROka57DB-in-
fected cells. (B) Cells infected with VZV ROka, ROka57DA, or ROka57DB
express proteins of 60–100 kDa that react with monoclonal antibody to
VZV gE. Numbers refer to molecular weight of proteins in kilodaltons.
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cation in cell culture indicates that the VZV gene
differs substantially from its PRV counterpart. In con-
trast to PRV, VZV is highly cell associated in vitro and
little or no cell-free virus is released into the medium.
Thus, future ultrastructural studies will be required to
determine the role of the VZV ORF57 protein in virion
maturation and spread in vitro.
MATERIALS AND METHODS
Cells and viruses
MeWo (human melanoma) cells were used for trans-
fections and preparation of virus stocks. Recombinant
viruses were derived from cosmids corresponding to the
attenuated Oka strain of VZV.
Plasmids and cosmids
VZV cosmids NotI A, MstII A, and MstII B and plas-
mid NotI B contain the entire VZV genome (Fig. 5). To
produce VZV with a deletion in ORF57, the MstIIA
cosmid was cut with NheI, which cuts at VZV nucleo-
tides 91,047 and 100,741, and the 9.7-kb fragment was
inserted into the NheI site of plasmid Litmus 38 (New
England Biolabs, Beverly, MA) in which the DraIII site
had been ablated previously. Because DraIII recog-
nizes CACNNNGTG, the DraIII site of plasmid Litmus
38 was ablated, and two new DraIII sites, correspond-
ing to the DraIII sites near ORF57 (VZV nucleotides
98,632 and 99,818) were inserted. Oligonucleotides
CTAGTCCACGTTGTGGA and AGCTTCCACAACGTGGA
were used to insert the first DraIII site at the SpeI and
HindIII sites of the plasmid, and oligonucleotides GATC-
CCCACGGGGTGCG and AATTCGCACCCCGTGGG were
used to insert the second DraIII site at the BamHI and
EcoRI sites of the plasmid. The resulting plasmid, pLit38-
DraIII-2, was cut with DraIII, and the 1.2-kb DraIII frag-
ment containing ORF57 from the NheI plasmid was in-
serted. The resulting plasmid was cut with AgeI and
BsiWI (which cut at VZV nucleotides 99,450 and 99,616),
and two oligonucleotides, CCGGTTACGTTCTC and GTAC-
GAGAACGTAA were annealed and ligated into the AgeI
and BsiWI sites of the plasmid. The latter oligonucleo-
tides were used to restore the 39 carboxyl terminus of
ORF58, which overlaps the first 17 nucleotides of ORF57.
The sequence of the inserted oligonucleotides was con-
firmed in two independent plasmid clones. The two
clones then were cut with DraIII, and the mutated DNAs
were inserted into the NheI plasmid. The latter then were
cut with NheI, and the ORF57 mutant DNA was inserted
into cosmid MstII A to produce cosmids MstII A-57DA
and MstII A-57DB. These cosmids have a 152-nucleotide
deletion that begins 20 nucleotides after the start of
ORF57 and ends 41 nucleotides before the stop codon of
ORF57.
Transfections
Cosmids were digested with NotI or Bsu36I to linear-
ize the DNAs. To produce VZV with a deletion in ORF57,
cells were transfected with 1 mg of cosmid NotI A, MstII
B, 0.5 mg of cosmid MstII A-57D, 1 mg of plasmid NotI B,
50 ng of plasmid pCMV62, and 2 mg of salmon sperm
DNA. Transfection of MeWo cells was performed as
previously described (Cohen and Seidel, 1993).
FIG. 3. Southern blot of virion DNAs from VZV ORF57 deletion
mutants. (A) Virion DNA digested with EcoRI and probed with all four
radiolabeled cosmids shows no rearrangement of the genome. (B)
Digestion of ROka57D with SphI followed by hybridization with a probe
from the ORF57 region of VZV shows that a 1.8-kb band in ROka is
reduced in size to 1.6 kb in ROka57D due to the deletion in ORF57.
Numbers refer to molecular weights in kilobase pairs.
FIG. 4. Growth of VZV ROka, ROka57DA, and ROka57DB in Mewo
cells. MeWo cells were inoculated with VZV-infected cells, and at
various times after infection the cells were harvested and the titer of
virus was determined in MeWo cells.
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Southern and Northern blots
VZV DNA was purified from nucleocapsids, cut with
EcoRI or SphI, fractionated on agarose gels, and trans-
ferred to nylon membranes. The four DNA cosmids span-
ning the entire VZV genome were radiolabeled with
[32P]dCTP and hybridized to the immobilized VZV DNA.
An NheI fragment, containing VZV nucleotides to 91,047–
100,741, was radiolabeled and used to demonstrate the
ORF57 mutation.
Growth characteristics of recombinant VZV
Growth curves for recombinant VZV were performed
by infecting MeWo cells with cells containing about 100
pfu of VZV. At days 1, 2, 3, 4, and 5 after infection, the cells
were harvested, and serial dilutions were used to inoc-
ulate uninfected MeWo cells. Plaques were stained and
counted 7 days after infection.
Generation of ORF57 fusion proteins
The coding region of VZV ORF57, from codons 11–71,
was amplified from VZV cosmid DNA by PCR. The first
primer contained a BamHI site followed by VZV nucleo-
tides 99,576–99,596 (CGCGGATCCAATGCCAGCGTTGC-
CACGCCG), and the second primer contained an EcoRI
site followed by VZV nucleotides 99,414–99,434 (CGC-
GAATTCACGTTGATGAGCCTTGCAGGT). The amplified
DNA was digested with BamHI and EcoRI and inserted
into plasmid pGEX-2T, and the sequence of the junction
of the ORF57 DNA and pGEX-2T DNA was confirmed.
Escherichia coli containing the plasmid expressing the
GST-ORF57 fusion protein were grown in 2XYT medium
with 2% glucose and ampicillin, and IPTG was added.
The bacteria were lysed by sonication, and the GST-
ORF57 fusion protein was bound to glutathione–Sepha-
rose, washed extensively, eluted with reduced glutathi-
one, and dialyzed.
Antibodies, immunoprecipitation, in vitro translation,
and cell fractionation studies
Rabbits were immunized once with 150 mg of GST-
ORF57 fusion proteins in complete Freund’s adjuvant
and two additional times in incomplete Freund’s adju-
FIG. 5. Construction of recombinant VZV with a deletion in ORF57. The VZV genome is 124,884 bp in length (line 1) and contains unique long (UL),
unique short (US), terminal repeat (TR), and internal repeat (IR) DNA sequences (line 2). NotI and MstII restriction fragments used to generate parental
VZV are shown (lines 3 and 4). Cosmid MstII A-57D (line 5) has a deletion beginning at codon 7 and ending at codon 58. Numbers for cosmid MstII
A-57D indicate the site of the deletion. This site is generated by oligonucleotides inserted at the AgeI and BsiWI restriction endonuclease sites. Two
identical, independent cosmid clones, MstIIA-57DA and MstIIA-57DB, were used to construct viruses with a deletion in ORF57. Restriction
endonuclease sites used for construction of cosmid MstII A-57D (line 6) and location of VZV open reading frames in this region (line 7) are shown.
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vant. Antiserum was obtained and absorbed four times
with lysates of uninfected MeWo cells.
VZV-infected and uninfected cells were radiolabeled
with [35S]methionine or [32P]orthophosphoric acid and
lysed. The supernatant was incubated with rabbit anti-
body to ORF57 protein or monoclonal antibody to VZV gE
(Chemicon, Temecula, CA) followed by protein A–Sepha-
rose. Immune complexes were fractionated on SDS–
polyacrylamide gels. Membrane and cytosolic fractions
from VZV-infected MeWo cells were prepared as previ-
ously described (Cohen and Seidel, 1995).
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